drugset / Trial / NCT05921058

The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients

NCT05921058

Phase 1/2 Completed 15 enrolled Universitas Sebelas Maret
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research is a clinical trial of administering mesenchymal stem cell secretome to lupus patients.

Timeline

Start
2022-08-01
Primary completion
2022-12-30
Completion
2023-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Secretome Other / unclassified 1.5 ml

Indications